Tirzepatide dosage at a glance
- Start at 2.5 mg once weekly for 4 weeks to improve gastrointestinal tolerance.
- Increase by 2.5 mg every 4 weeks if tolerated: 5 mg → 7.5 mg → 10 mg → 12.5 mg → up to 15 mg once weekly.
- Maximum recommended dose in most labels is 15 mg once weekly; many people remain at 5–10 mg based on goals and tolerance.
- Administer subcutaneously in the abdomen, thigh or upper arm, rotating injection sites each week.
- Missed dose: take within 4 days (96 hours), otherwise skip and resume on your regular day.
Forms and strengths available
Tirzepatide is supplied as single‑dose, pre‑filled autoinjector pens in multiple strengths that align with the titration schedule. Common strengths include 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg per injection for once‑weekly use.
- Each pen delivers a fixed dose once weekly.
- Pens are typically stored refrigerated before first use and may be kept at room temperature for a limited time as per product information. Always check your specific pen’s storage instructions.
In Australia, tirzepatide is registered for type 2 diabetes, and doctors may consider use for weight management based on individual clinical need. Availability and brand names can vary by market and time. Confirm current local access with your prescriber or pharmacist.
How to titrate tirzepatide (typical schedule)
Dose increases are based on tolerance, clinical goals and side effects. A common schedule is:
- Weeks 1–4: 2.5 mg once weekly
- Weeks 5–8: 5 mg once weekly
- Weeks 9–12: 7.5 mg once weekly
- Weeks 13–16: 10 mg once weekly
- Weeks 17–20: 12.5 mg once weekly
- Weeks 21+: 15 mg once weekly if needed and tolerated
If gastrointestinal symptoms are troublesome at any step, remain at the current dose longer, or consider stepping back one level before trying to increase again.
Weight loss vs diabetes dosing
The titration steps are generally similar whether the aim is weight management or type 2 diabetes control. Key differences relate to other medicines and monitoring:
- If you use insulin or sulfonylureas, your prescriber may reduce those doses to reduce hypoglycaemia risk as tirzepatide is increased.
- People focused on weight loss may stay longer at lower steps (for example 5–10 mg) if results are adequate and side effects are minimal.
Switching from another GLP‑1 medicine
When moving from a weekly GLP‑1 agonist (such as semaglutide), a common clinical approach is to start tirzepatide about 1 week after the last injection of the previous medicine. Many prescribers begin at 2.5 mg once weekly and then titrate in the usual steps based on tolerance.
- A slower re‑titration may be preferred if you previously had significant GI side effects.
- Do not overlap weekly injections without explicit medical advice.
How to inject tirzepatide correctly
- Inject once weekly on the same day each week, any time of day, with or without food.
- Choose abdomen, thigh, or upper arm subcutaneous tissue and rotate sites.
- Do not inject into areas that are tender, bruised, scarred, or with lipohypertrophy.
- Missed dose: take within 4 days (96 hours). If more than 4 days have passed, skip and resume on your usual day.
For step‑by‑step injection basics, see our technique overview.
About online “protocols” and compounded tirzepatide claims
You may see protocols online that suggest faster titration, mixing with vitamin B12, or the use of multi‑dose vials. Keep in mind:
- Official dosing is based on once‑weekly, single‑dose prefilled pens and 4‑week step intervals.
- Compounded or vial‑based products may vary in concentration, sterility and dosing accuracy. In Australia, supply and advertising of compounded tirzepatide are tightly regulated, and quality can differ between providers.
- Adding vitamins does not “cancel” side effects; the safest way to manage intolerance is slower titration or pausing increases under medical supervision.
If you are unsure whether a protocol is appropriate for you, discuss it with a qualified prescriber who can consider your medical history and current medicines.
Safety checks that influence dosage
Dose decisions should factor in the following risks and warnings commonly noted in product information for GLP‑1/GIP therapies:
- Severe or persistent abdominal pain: seek urgent review to rule out pancreatitis.
- Gallbladder issues: report right‑upper abdominal pain, fever, jaundice or pale stools.
- Thyroid C‑cell tumours: discuss personal/family history of medullary thyroid carcinoma (MTC) or MEN2 before starting.
- Diabetic retinopathy: rapid glucose improvements can temporarily worsen retinopathy; eye monitoring may be needed.
- Hypoglycaemia: more likely when combined with insulin or sulfonylureas; your doctor may reduce those doses.
- Pregnancy and breastfeeding: not recommended; discuss contraception and planning.
- Kidney and liver function: no routine dose adjustment is required in labels, but clinicians monitor closely, especially if significant GI losses lead to dehydration.
Practical tips for smoother titration
- Eat smaller, slower meals; limit high‑fat or very large portions during the first weeks of each increase.
- Stay hydrated and consider electrolyte balance if you have vomiting or diarrhoea.
- If nausea is significant, remain at the current step longer before increasing.
- Use a consistent weekly reminder and rotate injection sites methodically.
Tirzepatide dosage FAQs
What is the usual starting dose of tirzepatide?
2.5 mg once weekly for 4 weeks, then increase if tolerated.
How quickly should I increase the dose?
Commonly every 4 weeks by 2.5 mg, pausing longer if side effects persist.
What is the highest dose?
Often 15 mg once weekly is the maximum labelled dose. Many people do well at 5–10 mg.
Is the dosing different for weight loss vs diabetes?
The steps are similar. Other diabetes medications may need adjustment to prevent hypoglycaemia.
What if I miss a dose?
Take it within 4 days. If more than 4 days have passed, skip and take the next dose on your usual day.
Can I split the weekly dose?
Product information supports once‑weekly dosing. Only deviate if your prescriber specifically advises it.
Do drinks or food timing matter?
No, tirzepatide can be taken any time of day with or without food. Many people find smaller meals help during titration.
How long until I notice effects?
Appetite effects may appear within weeks; metabolic and weight changes often build over months as dose increases and lifestyle changes take effect.
Where can I read more Australia‑specific guidance?
See our guides on access, cost and prescription pathways linked in the sidebar and below.
Need help with tirzepatide dosing or access?
Send a message and we’ll connect you with information or providers who can advise on eligibility, dosing and next steps in Australia.
Key takeaway
Tirzepatide dosing is a gradual, once‑weekly titration. Starting at 2.5 mg and increasing every 4 weeks helps most people find the balance between results and tolerability. If side effects are significant, slow down increases and seek medical advice. Individual history, concurrent medicines and goals determine the “right” dose.